Shop

What is Enhertu?

Enhertu (trastuzumab deruxtecanmedication) is a monoclonal antibody and topoisomerase inhibitor conjugate used to treat certain types of breast cancer. Enhertu attacks HER2 cancer cells by stopping them from dividing and growing.

Generic Name: fam-trastuzumab deruxtecan
Brand Name: Enhertu

Uses of Enhertu (trastuzumab deruxtecanmedication):

Enhertu used in the treatment of HER2+ breast cancer of certain types as below:

• metastatic (has spread to such as the bones, liver, brain, or lungs(other body parts)).
• unresectable (surgery is not possible)

Side effects of Enhertu:

• Diarrhea.
• Dizziness.
• Stomach/Abdominal Pain.
• Constipation, Nausea.
• Vomiting, Mouth Sores.
• Dry Mouth.
• Loss Of Appetite.
• Tiredness.
• Hair Loss.
• Nose Bleeds, Or Headache May Occur.

Tell your doctor if any side effects persist, or any serious side effect occurs.

Precations before taking Enhertu

• Make sure you are not allergic to Enhertu.
• Explain all your medical history to your doctor.
• May worsen infections.
• Driving is not recommended.
• Not recommended in pregnancies.
• Avoid breastfeeding.